Summary
We examined tumor infiltrating leukocytes (TIL) in frozen sections of 28 biopsies from squamous cell carcinomas of the head and neck (SCCHN). In so doing, we used monoclonal antibodies (MoAb) directed against various leukocyte antigens. As defined by HLe-1+ cells, leukocyte infiltration was present in all biopsies. The amount of HLe-1+ cells was more often greater in stage III than in stage IV lesions. Most of the TIL were identified as CD5+ T-lymphocytes. In contrast, CD19+ B-cells were sparse in most biopsies. CD14+ monocytes/ macrophages were found in only a few specimens. The relative proportion of CD4+ T-helper cells was higher than or at least equal to CD8+ suppressor/ cytotoxic cells in all samples tested. Interleukin-2 (IL-2) receptor+ lymphocytes were evident in 13 of 22 biopsies stained for CD25 reactivity, and were more often observed in stage III than in stage IV tumors. All biopsies from recurrent tumors had no detectable IL-2 receptor+ cells.
Our findings provide evidence for a positive correlation between a greater amount of TIL in earlier stages of SCCHN. The presence of IL-2+ lymphocytes suggests that SCCHN may be capable of activating resting lymphocytes for further IL-2¡nduced proliferation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Joint Committee for Cancer Staging and End-Result Reporting (1978) Manual for staging on cancer. AJC, Chicago
Bhan AK, Des Marais CL (1983) Immunohistologic characterization of major histocompatibility antigen and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst 71:507–516
Böheim K, Schwarzfurtner H, Böheim C, Frei E III, Bernal SD (1986) Immunohistochemical identification of squamous carcinoma of the head and neck with monoclonal antibody SQM1. Acta Otolaryngol (Stockh) 102: 333–340
Claudy AL, Viac J, Schmitt D, Alaris A, Thivolet J (1976) Identification of mononuclear cells infiltrating basal cell carcinomas. Acta Derm Venereol (Stockh) 56:361–365
Eremin O, Coombs RRA, Prospero TD, Plumb D (1982) T-lymphocyte and B-lymphocyte subpopulations infiltrating human mammary carcinomas. J Natl Cancer Inst 69:1–8
Gattringer C, Huber H, Radaszkiewicz T, Pfaller W, Braunsteiner H (1984) Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis. Int J Cancer 33:751–757
Harabuchi Y, Yamanaka N, Kataura A (1985) Identification of lymphocyte subsets and natural killer cells in head and neck cancers. An immunohistochemical study using monoclonal antibodies. Arch Otorhinolaryngol 242:89–97
Hiratsuka H, Imamura M, Kasai K, Kamiya H, Ishii Y, Kohama GI, Kikuchi K (1983) Lymphocyte subpopulations and T-cell subsets in human oral cancer tissues: immunohistologic analysis by monoclonal antibodies. Am J Clin Pathol 464–470
Huber H, Pastner D, Gabl F (1983) Laboratoriumsdiagnose hämatologischer Erkrankungen, Vol 1. Hämatologie und Immunhämatologie. Springer, Berlin Heidelberg New York, S 464–467
Hurlimann J, Saraga P (1985) Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. Int J Cancer 35:753–762
Jacobsson PA (1980) Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx. In: Alberti PW, Bryce DP (eds) Centennial Conference of Laryngeal Cancer. Appleton-Century-Crofts, New York, pp 847–854
Ioachim HL (1976) The stromal reaction of tumors: an expression of immunosurveillance. J Natl Cancer Inst 57: 456–475
Ioachim HL, Dorsett BH, Paluch E (1976) The immune response at the tumor site in lung carcinoma. Cancer 38: 2296–2309
Jondal M, Klein G (1975) Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies. Biomedicine 23:163–165
Larsson EL, Couthino A (1979) The role of mitogenic leetins in T-cell triggering. Nature 280:239–241
Majdic O, Bettelheim P, Stockinger H, Aberer W, Liszka K, Lutz D, Knapp W (1984) M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells. Int J Cancer 33:617–623
Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318–1321
Rowe DJ, Beverley PCL (1984) Characterization of breast cancer infiltrates using monoclonal antibodies to human leukocyte antigens. Br J Cancer 49:149–159
Stendahl U, Ekland G, Willens R (1983) Prognosis of invasive squamous cell carcinoma of the uterine cervix: a comparative study of the predictive values of clinical staging IB-III and a histopathologic malignancy grading system. Int J Gynecol Pathol 2:42–45
Uchiyama T, Broder S, Waldmann TA (1981) A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T-cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac(+) cells. J Immunol 126:1393–1397
Vose BM, Moore M (1979) Suppressor cell activity of lymphocytes infiltrating human lung and breast tumors. Int J Cancer 24:578–585
Vose BM, Moore M (1985) Human tumor infiltrating lymphocytes: a marker of host response. Semin Hematol 22:27–40
Waldmann TA (1986) The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727–723
Whitwell HL, Hughes HPA, Moore M, Ahmed A (1984) Expression of major histocompatibility antigens and leukocyte infiltration in benign and malignant breast disease. Br J Cancer 49:161–172
Zeromski J, Szmeja A, Kruk-Zagajewska A (1986) Immunofluorescent assessment of tumor infiltrating cells in laryngeal carcinoma. Acta Otolaryngol (Stockh) 102:325–332
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Böheim, K., Denz, H., Böheim, C. et al. An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes. Arch Otorhinolaryngol 244, 127–132 (1987). https://doi.org/10.1007/BF00458563
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00458563